InMed Pharmaceuticals Inc. (NASDAQ:INM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 11, 2026.
The Healthcare company reported Q0 revenue of .
InMed Pharmaceuticals Inc.'s stock currently trades at $0.99 with a market capitalization of $2.5M.